An interventional study to compare the effect of steroid injection versus dextrose prolotherapy in management of medial heel pain

An interventional study compararive study to compare the effect of Ultrasound-Guided methylpredinsolone acetate injection versus dextrose prolotherapy in management of plantar fasciitis - Nill

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066454

Enrollment

Registered

2024-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: Ultrasound guided steroid injection versus dextrose prolotherapy in management of plantar fasciitis: After applying coupling gel (sterile 2% lignocaine jelly),a 6-13MHz linear array tra

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients of chronic plantar fasciitis 2. Those giving signed informed consent for study 3. Patients is not a part of any other study 4. Numeric Rating Scale score more than4 Duration of symptoms more than 2 months

Exclusion criteria

Exclusion criteria: 1.History of any surgery or injection to the plantar fascia/heel in last 6 months. 2.History of trauma, fracture to heel or any other surgeries leading to any functional limitation of the affected foot. 3.Other medical/surgical condition other than PF producing heel symptoms: like peripheral neuropathy, positive tinel’s sign at the medial ankle, ischemia, systemic inflammation and connective tissue disease; history of disc herniation, etc. 4.History of any systemic disorders or bleeding disorders or intake of anticoagulants or other medical conditions where steroid/dextrose injection is contraindicated like uncontrolled diabetes, coagulation disorders, paresthesia or numbness at heel, presence of cyst, mass, or local skin infection at the site of pain. 5.Pregnant or lactating mothers. 6.Any special treatment taken in the past 4 weeks with interfere the outcome assessment, including iontophoresis, phonophoresis, and shockwave therap

Design outcomes

Primary

Measure	Time frame
1. Pain intensity with Numeric Rating Scale (NRS) 2. Functional outcome measure with A. The Foot and Ankle Ability Measure (FAAM) B. Foot Function Index (FFI) 3. Ultrasonographic assessmentsTimepoint: NRS,FAAM,FFI and USG assessments at baseline, 2 weeks and 12 weeks	—

Secondary

Measure	Time frame
Functional outcome measure With A The Foot & Ankle Ability Measure B Foot Function IndexTimepoint: FAAM FFI measure at 8 weeks	—

Countries

India

Contacts

Public ContactDR OMPARKASH

SMS Medical College Jaipur

opurmi@yahoo.com7597202012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026